We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing

By HospiMedica International staff writers
Posted on 02 May 2024

The kidneys are essential organs that handle critical bodily functions, including waste elimination and blood pressure regulation. More...

Often referred to as the silent organ because they typically do not manifest symptoms until there is significant damage, early detection of kidney tumors is vital as it enables removal through partial nephrectomy. However, this surgery carries risks such as severe bleeding, infections, and tissue damage, leading to potential chronic conditions like reduced kidney function and hypertension, complicating both the treatment and recovery phases. In response to these challenges, researchers have created a new material designed to quickly stop kidney bleeding and aid in wound healing.

Using kidney-derived decellularized extracellular matrix (dECM), a team of researchers from Pohang University of Science & Technology (POSTECH, Gyeongbuk. Korea) has developed a hemostatic solution specifically tailored for kidney applications. The dECM material contains proteins and factors that replicate the natural environment of the kidney, ensuring compatibility with human tissue. This material has already seen applications in tissue engineering, including artificial organ creation and tissue restoration. The team first analyzed the composition of the kidney-derived dECM to confirm the presence of hemostatic elements within its structure. They then combined this dECM with a chemical cross-linker to create a porous sponge-like material known as "cryogel."

This cryogel is designed to be highly porous with an expansive surface area, allowing it to effectively absorb blood, which is particularly useful in surgical settings. In animal trials, the cryogel demonstrated a notable reduction in tissue damage and necrosis by up to threefold four weeks after partial nephrectomy, outperforming both the control group and conventional gelatin sponges. Furthermore, the researchers found that the level of cross-linker used significantly impacts the cryogel's biodegradation rate and compatibility with blood, highlighting its potential for enhancing post-surgical recovery in kidney treatments.

"This study underscores once more the clinical significance of dECM-based medical sponge materials," said Professor Dong-Woo Cho from POSTECH.

Related Links:
POSTECH


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.